Uniplan Investment Counsel, Inc. - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 132 filers reported holding NEOGENOMICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Uniplan Investment Counsel, Inc. ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q1 2021$2,896,000
-74.2%
60,049
-71.2%
0.18%
-75.9%
Q4 2020$11,245,000
+18.1%
208,866
-19.1%
0.77%
+15.7%
Q3 2020$9,524,000
+19.2%
258,191
+0.1%
0.66%
+19.2%
Q2 2020$7,993,000
+10.1%
258,022
-1.8%
0.56%
+1.8%
Q1 2020$7,257,000
+9.2%
262,850
+15.7%
0.55%
+38.8%
Q4 2019$6,646,000
+54.1%
227,220
+0.7%
0.39%
+47.0%
Q3 2019$4,314,000
-17.6%
225,635
-5.5%
0.27%
-19.3%
Q2 2019$5,236,000
-15.0%
238,668
-20.7%
0.33%
-14.9%
Q1 2019$6,157,000
-21.3%
300,969
-51.5%
0.39%
-27.6%
Q4 2018$7,827,000
-20.6%
620,767
-3.4%
0.54%
-6.1%
Q3 2018$9,862,000
+3.8%
642,538
-11.3%
0.57%
+23.4%
Q2 2018$9,499,000
+34.5%
724,594
-16.3%
0.46%
+40.5%
Q1 2018$7,062,000
-5.9%
865,540
+2.1%
0.33%
+8.2%
Q4 2017$7,508,000
-19.6%
847,483
+1.0%
0.31%
-22.5%
Q3 2017$9,341,000
+33.0%
839,310
+7.1%
0.40%
+28.2%
Q2 2017$7,022,000
-2.1%
783,804
-13.8%
0.31%
-5.2%
Q1 2017$7,176,000
-3.1%
909,528
+5.2%
0.32%
-3.6%
Q4 2016$7,406,000
+1.8%
864,263
-2.4%
0.34%
+3.1%
Q3 2016$7,278,000
+4.2%
885,427
+1.9%
0.33%
+3.5%
Q2 2016$6,983,000
+26.1%
868,567
+5.7%
0.32%
+16.2%
Q1 2016$5,539,000
-14.1%
821,860
+0.3%
0.27%
-13.1%
Q4 2015$6,446,000
+22.8%
819,150
-10.6%
0.31%
+23.7%
Q3 2015$5,250,000
+2.0%
916,352
-3.7%
0.25%
+8.1%
Q2 2015$5,146,000951,2050.23%
Other shareholders
NEOGENOMICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Kopp Family Office, LLC 2,023,355$91,395,00037.83%
Blue Water Life Science Advisors, LP 702,222$31,719,00011.94%
Burrage Capital Management LLC 147,921$6,682,0006.70%
PERKINS CAPITAL MANAGEMENT INC 158,300$7,150,0004.06%
First Light Asset Management, LLC 1,148,945$51,898,0003.11%
Soleus Capital Management, L.P. 352,007$15,900,0002.44%
Ranger Investment Management 832,286$37,594,0001.96%
Avidity Partners Management LP 1,367,000$61,747,0001.67%
Bullseye Asset Management LLC 108,672$4,909,0001.65%
Tygh Capital Management, Inc. 255,541$11,543,0001.57%
View complete list of NEOGENOMICS INC shareholders